OOIR: Observatory of International Research

Papers

(The H4-Index of Seminars in Arthritis and Rheumatism is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Gout epidemiology and comorbidities	164
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease	115
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs	114
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities	96
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis	96
The biology of urate	84
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review	82
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review	82
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies	76
Understanding differences between men and women with axial spondyloarthritis	65
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States	59
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020	58
Therapeutic approaches in the treatment of gout	57
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients	50
Axial involvement in psoriatic arthritis: An update for rheumatologists	49
Antisynthetase syndrome – much more than just a myopathy	48
What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review	48
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	47
Addressing the rheumatology workforce shortage: A multifaceted approach	45
COVID-19 in rheumatic disease patients on immunosuppressive agents	45
Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis	45
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems	41
Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis	40
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?	40
Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis	40

Effectiveness of tocilizumab in Behcet's disease: A systematic literature review	39
The ASAS-OMERACT core domain set for axial spondyloarthritis	37
Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review	37
Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa	36
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study	35
Advances in our understanding of gout as an auto-inflammatory disease	35
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO regi	34
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data	33
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review	33